KRT18, a cytoskeletal protein essential for cellular integrity, is suggested to be overexpressed in most cancer types, including liver, colon, and NSCLC, and is associated with their advanced clinical stage, metastasis, malignant status, and poor prognosis and survival in patients [56,83,84]. This evidence concerns the gene DNM2 and cancer.